Genetic Study of Nephrolithiasis in Gouty Diathesis
Sponsor: Mario Negri Institute for Pharmacological Research
Terminated
Non significative preliminary data
Other terminated trials from Mario Negri Institute for Pharmacological Research
- Breast Neoplasm Female · Phase PHASE2 · Jan 2025
- Hyperkalemia · Phase PHASE3 · Nov 2024
- Fallopian Tube Cancer · Phase PHASE2 · Aug 2024
- Lung Cancer · Phase PHASE3 · Sep 2022
- Open Angle Glaucoma · Phase NA · Apr 2022
See all terminations from Mario Negri Institute for Pharmacological Research
Other Nephrolithiasis trials with similar outcome
A observational or N/A phase clinical study on Nephrolithiasis, this trial is terminated or withdrawn. The trial is conducted by Mario Negri Institute for Pharmacological Research and has accumulated 11 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
May 2023 — Jul 2024 [monthly]
Terminated
-
Dec 2021 — May 2023 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mario Negri Institute for Pharmacological Research
For direct contact, visit the study record on ClinicalTrials.gov .